Go Pro

C4 Therapeutics (CCCC) Institutional Ownership

C4 Therapeutics logo
$3.74 -0.05 (-1.32%)
As of 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for C4 Therapeutics (NASDAQ:CCCC)

Current
Institutional Ownership
Percentage
78.81%
Number of
Institutional Buyers
(last 12 months)
54
Total
Institutional Inflows
(last 12 months)
$53.32M
Number of
Institutional Sellers
(last 12 months)
14
Total
Institutional Outflows
(last 12 months)
$25.62M
Get CCCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling C4 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CCCC Institutional Buying and Selling by Quarter

C4 Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/27/2026 Corient Private Wealth LP10,007$47K0.0%-53.2%0.008%
8/24/2026 California State Teachers Retirement System6,519$30K0.0%N/A0.005%
8/22/2026 Seven Fleet Capital Management LP381,169$1.78M0.3%+567.8%0.310%
8/21/2026 AXQ Capital LP10,745$50K0.0%-87.5%0.009%
8/21/2026 Velan Capital Investment Management LP570,000$2.66M1.6%N/A0.463%
8/20/2026 Headlands Technologies LLC153,972$719K0.1%N/A0.125%
8/19/2026 Wellington Management Group LLP227,768$1.06M0.0%N/A0.185%
8/6/2026 Bank of New York Mellon Corp249,517$1.17M0.0%N/A0.226%
7/10/2026 Wasatch Advisors LP3,522,644$16.45M0.1%+18.9%3.186%
6/4/2026 Seven Fleet Capital Management LP57,076$150K0.0%N/A0.052%
5/21/2026 CTC Alternative Strategies Ltd.10,792$28K0.1%N/A0.010%
5/19/2026 Bank of America Corp DE2,359,241$6.21M0.0%-1.2%2.134%
5/19/2026 Stempoint Capital LP453,236$1.19M0.2%N/A0.410%
5/18/2026 ADAR1 Capital Management LLC43,000$113K0.0%N/A0.039%
5/18/2026 Readystate Asset Management LP49,586$130K0.0%N/A0.045%
5/16/2026 SummitTX Capital L.P.10,466$28K0.0%N/A0.009%
5/16/2026 Orbimed Advisors LLC856,353$2.25M0.0%-39.0%0.774%
5/15/2026 OMERS ADMINISTRATION Corp59,700$157K0.0%-49.3%0.054%
5/14/2026 Renaissance Technologies LLC2,461,815$6.48M0.0%+53.6%2.234%
5/14/2026 Sei Investments Co.25,134$66K0.0%N/A0.023%
5/7/2026 Dimensional Fund Advisors LP442,518$1.16M0.0%+49.3%0.402%
4/21/2026 Wasatch Advisors LP2,961,761$7.79M0.1%-31.8%3.035%
2/23/2026 Virtu Financial LLC20,655$39K0.0%N/A0.021%
2/19/2026 Invesco Ltd.268,350$513K0.0%+39.9%0.277%
2/18/2026 XTX Topco Ltd104,458$200K0.0%-30.3%0.108%
2/18/2026 Quadrature Capital Ltd133,112$254K0.0%N/A0.137%
2/18/2026 Orbimed Advisors LLC1,404,902$2.68M0.1%-73.2%1.450%
2/18/2026 Millennium Management LLC1,188,969$2.27M0.0%-41.3%1.227%
2/18/2026 Man Group plc156,098$298K0.0%+72.9%0.161%
2/18/2026 Intrepid Family Office LLC55,000$105K0.1%-21.4%0.057%
2/18/2026 Engineers Gate Manager LP24,416$47K0.0%+49.9%0.025%
2/18/2026 Bridgeway Capital Management LLC131,100$250K0.0%+64.1%0.135%
2/18/2026 683 Capital Management LLC400,000$764K0.0%N/A0.413%
2/17/2026 RA Capital Management L.P.8,000,000$15.28M0.2%N/A8.255%
2/17/2026 Bain Capital Life Sciences Investors LLC7,171,910$13.70M1.0%+545.0%7.401%
2/17/2026 Atom Investors LP104,964$200K0.0%N/A0.108%
2/17/2026 ExodusPoint Capital Management LP62,165$119K0.0%N/A0.064%
2/17/2026 Graham Capital Management L.P.102,198$195K0.0%+151.5%0.105%
2/16/2026 Squarepoint Ops LLC136,054$260K0.0%+1,247.2%0.140%
2/16/2026 OMERS ADMINISTRATION Corp117,700$225K0.0%N/A0.121%
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
2/16/2026 Barclays PLC219,204$419K0.0%+409.0%0.226%
2/13/2026 Marshall Wace LLP265,027$506K0.0%+149.4%0.273%
2/13/2026 Hudson Bay Capital Management LP111,551$213K0.0%N/A0.115%
2/13/2026 Charles Schwab Investment Management Inc.449,432$858K0.0%+28.2%0.464%
2/13/2026 State Street Corp342,773$655K0.0%+19.3%0.354%
2/13/2026 Wells Fargo & Company MN809,260$1.55M0.0%+4,236.9%0.835%
2/12/2026 Wasatch Advisors LP4,344,918$8.30M0.0%-10.5%4.483%
2/12/2026 Jane Street Group LLC874,794$1.67M0.0%+329.7%0.903%
2/12/2026 Renaissance Technologies LLC1,602,580$3.06M0.0%+71.0%1.654%
2/12/2026 Dimensional Fund Advisors LP296,480$566K0.0%-15.1%0.306%
2/11/2026 LPL Financial LLC243,305$465K0.0%+21.1%0.251%
2/10/2026 Goldman Sachs Group Inc.1,089,020$2.08M0.0%+136.8%1.124%
2/9/2026 Geode Capital Management LLC988,878$1.89M0.0%+36.3%1.020%
1/30/2026 Delta Investment Management LLC20,000$38K0.0%N/A0.021%
1/14/2026 Hennion & Walsh Asset Management Inc.237,137$453K0.0%+15.7%0.245%
11/19/2025 Caitong International Asset Management Co. Ltd19,146$43K0.0%N/A0.020%
11/17/2025 Jacobs Levy Equity Management Inc.503,145$1.12M0.0%+13.9%0.519%
11/17/2025 Voleon Capital Management LP28,420$63K0.0%N/A0.029%
11/17/2025 Wasatch Advisors LP4,852,741$10.77M0.1%-34.6%5.007%
11/17/2025 Qube Research & Technologies Ltd115,973$257K0.0%N/A0.120%
11/17/2025 Mariner LLC128,237$285K0.0%-3.4%0.132%
11/17/2025 Bank of America Corp DE2,053,162$4.56M0.0%+2.2%2.119%
11/17/2025 Algert Global LLC106,300$236K0.0%N/A0.110%
11/14/2025 Zacks Investment Management13,043$29K0.0%N/A0.018%
11/14/2025 Man Group plc90,278$200K0.0%+15.0%0.127%
11/14/2025 Orbimed Advisors LLC5,235,146$11.62M0.3%-23.4%7.356%
11/14/2025 Shay Capital LLC420,000$932K0.1%N/A0.590%
11/14/2025 Two Sigma Investments LP834,726$1.85M0.0%+22.1%1.173%
11/14/2025 Bridgeway Capital Management LLC79,900$177K0.0%-23.8%0.112%
11/13/2025 BNP Paribas Financial Markets80,806$179K0.0%-60.8%0.114%
11/13/2025Jefferies Financial Group Inc.38,200$85K0.0%N/A0.054%
11/12/2025 Dimensional Fund Advisors LP349,289$775K0.0%-19.1%0.491%
11/12/2025 R Squared Ltd17,880$40K0.0%-41.5%0.025%
11/7/2025 Crestwood Advisors Group LLC66,536$148K0.0%+129.4%0.093%
11/7/2025Vanguard Group Inc.3,191,557$7.09M0.0%+5.7%4.484%
11/4/2025 State of Wyoming82,509$183K0.0%N/A0.116%
8/15/2025 Tower Research Capital LLC TRC 40,592$58K0.0%+458.0%0.057%
8/15/2025 Wasatch Advisors LP7,424,662$10.62M0.1%+10.4%10.432%
8/15/2025 Man Group plc78,487$112K0.0%-8.3%0.110%
8/15/2025 BNP Paribas Financial Markets206,177$295K0.0%+1,039.4%0.290%
8/15/2025 Bridgeway Capital Management LLC104,900$150K0.0%-19.2%0.147%
8/15/2025 Bank of America Corp DE2,008,004$2.87M0.0%+0.9%2.821%
8/15/2025 Adage Capital Partners GP L.L.C.200,000$286K0.0%-87.1%0.281%
8/14/2025 Jane Street Group LLC492,612$704K0.0%+3,816.8%0.692%
8/13/2025 Invesco Ltd.155,017$222K0.0%+11.1%0.218%
8/12/2025 XTX Topco Ltd108,278$155K0.0%+170.0%0.152%
8/12/2025 Dynamic Technology Lab Private Ltd21,476$31K0.0%N/A0.030%
8/12/2025 Catalyst Funds Management Pty Ltd28,300$40K0.0%N/A0.040%
8/8/2025 Geode Capital Management LLC745,053$1.07M0.0%-47.9%1.049%
8/6/2025 Savant Capital LLC26,347$38K0.0%N/A0.037%
Porter flew 3,300 miles to investigate this system (Ad)

Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel

Watch the full investigation and decide for yourself
8/5/2025 Crestwood Advisors Group LLC29,000$41K0.0%N/A0.041%
8/1/2025 Y Intercept Hong Kong Ltd52,521$75K0.0%N/A0.074%
7/31/2025 R Squared Ltd30,587$44K0.0%N/A0.043%
7/30/2025 Brookstone Capital Management29,325$42K0.0%N/A0.041%
6/27/2025 Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%
5/29/2025Rhumbline Advisers89,633$143K0.0%-10.4%0.126%
5/21/2025Acadian Asset Management LLC27,675$43K0.0%N/A0.039%
5/16/2025Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%
5/16/2025Jacobs Levy Equity Management Inc.697,653$1.12M0.0%N/A0.983%
5/16/2025AQR Capital Management LLC140,532$225K0.0%+957.6%0.198%


CCCC Institutional Ownership - Frequently Asked Questions

During the previous two years, 116 institutional investors and hedge funds held shares of C4 Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($25.12M), Lynx1 Capital Management LP ($24.67M), Wasatch Advisors LP ($16.45M), RA Capital Management L.P. ($15.28M), Bain Capital Life Sciences Investors LLC ($13.70M), Vanguard Group Inc. ($7.09M), and Point72 Asset Management L.P. ($6.85M).Learn more on C4 Therapeutics' institutional investors.

78.81% of C4 Therapeutics' stock is owned by institutional investors. Learn more on CCCC's institutional investor holdings.

Of the 100 institutional investors that purchased C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($8M), Bain Capital Life Sciences Investors LLC ($6.06M), Wasatch Advisors LP ($2.49M), Renaissance Technologies LLC ($1.52M), Jane Street Group LLC ($1.20M), Adage Capital Partners GP L.L.C. ($1.03M), and Point72 Asset Management L.P. ($923.27K).

Institutional investors have bought a total of 24,054,571 shares in the last 24 months. This purchase volume represents approximately $53.32M in transactions.

Of the 14 institutional investors that sold C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Orbimed Advisors LLC ($5.97M), Wasatch Advisors LP ($4.46M), Millennium Management LLC ($835.26K), Dimensional Fund Advisors LP ($135.41K), BNP Paribas Financial Markets ($125.37K), AXQ Capital LP ($75.53K), and OMERS ADMINISTRATION Corp ($58K).

Institutional investors have sold a total of 11,808,880 shares in the last 24 months. This volume of shares sold represents approximately $25.62M in transactions.



Institutional ownership data for NASDAQ:CCCC is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/27/2026. New 13F filings are added each quarter as they're published.
From Our Partners